|Chemical and physical data|
|Molar mass||349.478 g·mol−1|
|3D model (JSmol)|
CUMYL-PINACA (also known as SGT-24) is an indazole-3-carboxamide based synthetic cannabinoid. CUMYL-PINACA acts as a potent agonist for the cannabinoid receptors, with approximately 3x selectivity for CB1, having an EC50 of 0.15nM for human CB1 receptors and 0.41nM for human CB2 receptors.
Sweden's public health agency suggested classifying CUMYL-PINACA as a hazardous substance, on November 10, 2014.